Related references
Note: Only part of the references are listed.Paradoxical gastrointestinal effects of interleukin-17 blockers
Pankti Mehta et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial
Hermine Brunner et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach
Yoshiya Tanaka et al.
NATURE REVIEWS RHEUMATOLOGY (2022)
IL-23 inhibition for the treatment of psoriatic arthritis
Raagav Mohanakrishnan et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2022)
Reflecting on the immunopathology of arthritis associated with inflammatory bowel disease: what do we know and what should we know?
Abhimanyu Amarnani et al.
CLINICAL RHEUMATOLOGY (2022)
Treatment of axial spondyloarthritis: an update
Abhijeet Danve et al.
NATURE REVIEWS RHEUMATOLOGY (2022)
Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use
Joeri W. van Straalen et al.
RHEUMATOLOGY (2022)
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
Laura C. Coates et al.
NATURE REVIEWS RHEUMATOLOGY (2022)
Autoimmune liver diseases in systemic rheumatic diseases
Chrong-Reen Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2022)
Time Trends in Psoriasis and Psoriatic Arthritis Incidence from 2002 to 2016 in Taiwan: An Age-Period-Cohort Analysis
Yu-Tsung Chen et al.
JOURNAL OF CLINICAL MEDICINE (2022)
A Review of Systemic Biologics and Local Immunosuppressive Medications in Uveitis
Neesurg S. Mehta et al.
JOURNAL OF OPHTHALMIC & VISION RESEARCH (2022)
Incidence of inflammatory bowel disease in patients with ankylosing spondylitis
Shih-Wei Lai et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Low Incidence of Inflammatory Bowel Disease Adverse Events in Adalimumab Clinical Trials Across Nine Different Diseases
Dirk Elewaut et al.
ARTHRITIS CARE & RESEARCH (2021)
Reactive arthritis: a clinical review
Ameen Jubber et al.
JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH (2021)
Ustekinumab for Extra-intestinal Manifestations of Inflammatory Bowel Disease: A Systematic Literature Review
Lucas Guillo et al.
JOURNAL OF CROHNS & COLITIS (2021)
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician
Ennio Lubrano et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2021)
Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management
Gerhard Rogler et al.
GASTROENTEROLOGY (2021)
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease
Daniel C. Baumgart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The Increased Levels of Fecal Calprotectin in Children With Active Enthesitis Related Arthritis and MRI Signs of Sacroiliitis: The Results of a Single Center Cross-Sectional Exploratory Study in Juvenile Idiopathic Arthritis Patients
Lovro Lamot et al.
FRONTIERS IN MEDICINE (2021)
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
Atul Deodhar et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity?
Ilaria Pagnini et al.
FRONTIERS IN MEDICINE (2021)
Recent Updates in Juvenile Spondyloarthritis
Hemalatha Srinivasalu et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2021)
Managing Psoriatic Arthritis With Inflammatory Bowel Disease and/or Uveitis
Alfred Yu Ting Chia et al.
FRONTIERS IN MEDICINE (2021)
Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis
Guillaume Pineton de Chambrun et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
The epidemiology of inflammatory bowel disease: East meets west
Wing Yan Mak et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Comorbidities associated with psoriatic arthritis: Review and update
Lourdes M. Perez-Chada et al.
CLINICAL IMMUNOLOGY (2020)
Update on therapeutic management of spondyloarthritis associated with inflammatory bowel disease
Dorra Ben Nessib et al.
CLINICAL RHEUMATOLOGY (2020)
Juvenile-Versus Adult-Onset Spondyloarthritis Similar, but Different
Pamela F. Weiss et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2020)
Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products
Karma Yeshi et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort
Dubois Evelyne et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)
Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis
Eric Gracey et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Juvenile Spondyloarthritis: focus on uveitis
Achille Marino et al.
PEDIATRIC RHEUMATOLOGY (2020)
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
Stefan Schreiber et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study
John D. Reveille et al.
JOURNAL OF RHEUMATOLOGY (2019)
Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study
Claire Liefferinckx et al.
JOURNAL OF CROHNS & COLITIS (2019)
Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment
George E. Fragoulis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis
Sarah Ringold et al.
ARTHRITIS & RHEUMATOLOGY (2019)
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Michael M. Ward et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease
Davide Giuseppe Ribaldone et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide population-based study
Hsu-Heng Yen et al.
INTESTINAL RESEARCH (2019)
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases (vol 16, pg 843, 2017)
Daniella M. Schwartz et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation
Scott M. Whitlock et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Juvenile Spondyloarthritis A Distinct Form of Juvenile Arthritis
Pamela F. Weiss et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2018)
The Seronegative Spondyloarthropathies
Ayyappa S. Duba et al.
PRIMARY CARE (2018)
Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases
Carla Felice et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Role of Subclinical Gut Inflammation in the Pathogenesis of Spondyloarthritis
Aroldo Rizzo et al.
FRONTIERS IN MEDICINE (2018)
Screening of Inflammatory Bowel Disease and Spondyloarthritis for Referring Patients Between Rheumatology and Gastroenterology
Jesus Sanz Sanz et al.
REUMATOLOGIA CLINICA (2018)
Histopathology of the gut in rheumatic diseases
F. Macaluso et al.
REUMATISMO (2018)
Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study
Rachel Charlton et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
The Prevalence and Incidence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Maren C. Karreman et al.
JOURNAL OF CROHNS & COLITIS (2017)
Reactive Arthritis
Steven K. Schmitt
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2017)
Antitumor Necrosis Factor-α Therapy Associated with Inflammatory Bowel Disease: Three Cases and a Systematic Literature Review
Amir Bieber et al.
JOURNAL OF RHEUMATOLOGY (2017)
The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes
Devy Zisman et al.
JOURNAL OF RHEUMATOLOGY (2017)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
Enthesitis: from pathophysiology to treatment
Georg Schett et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Psoriatic Arthritis
Christopher T. Ritchlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA
Desiree van der Heijde et al.
RHEUMATOLOGY (2017)
Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease
Benjamin L. Cohen et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease
Benjamin L. Cohen et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Rare occurrence of inflammatory bowel disease in a cohort of Han Chinese ankylosing spondylitis patients-a single institute study
Chrong-Reen Wang et al.
SCIENTIFIC REPORTS (2017)
Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts
Alessandro Armuzzi et al.
DIGESTIVE AND LIVER DISEASE (2017)
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits
Sasha Taleban et al.
JOURNAL OF CROHNS & COLITIS (2016)
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
Marcus Harbord et al.
JOURNAL OF CROHNS & COLITIS (2016)
Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong
Siew C. Ng et al.
INFLAMMATORY BOWEL DISEASES (2016)
Ankylosing Spondylitis and Axial Spondyloarthritis
Joel D. Taurog et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Global Prevalence of Spondyloarthritis: A Systematic Review and Meta-Regression Analysis
Carmen Stolwijk et al.
ARTHRITIS CARE & RESEARCH (2016)
Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
Kai-Chun Wu et al.
INTESTINAL RESEARCH (2016)
Juvenile spondyloarthritis
Sabrina Gmuca et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Recognizing and managing comorbidities in psoriatic arthritis
Alexis Ogdie et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Pathogenesis, Diagnosis, and Management of Ulcerative Proctitis, Chronic Radiation Proctopathy, and Diversion Proctitis
Xian-rui Wu et al.
INFLAMMATORY BOWEL DISEASES (2015)
Extraintestinal Manifestations of Inflammatory Bowel Disease
Stephan R. Vavricka et al.
INFLAMMATORY BOWEL DISEASES (2015)
Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics
Deborah Barthel et al.
JOURNAL OF RHEUMATOLOGY (2015)
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Dominique Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Axial spondyloarthritis
Joachim Sieper et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis
Carmen Stolwijk et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
Atul Deodhar et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies
Alessia Leone et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2015)
Golimumab May Induce Exacerbation of Inflammatory Bowel Disease When It Is Used for the Treatment of Ankylosing Spondylitis: A Case Report With A Review of Literature
Muhammad Z. Bawany et al.
AMERICAN JOURNAL OF THERAPEUTICS (2014)
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study
R. Landewe et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial
Feng Huang et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease
Ignazio Olivieri et al.
AUTOIMMUNITY REVIEWS (2014)
The meaning of low-grade inflammation in clinically quiescent inflammatory bowel disease
Alan C. Moss
CURRENT OPINION IN GASTROENTEROLOGY (2014)
Ulcerative proctitis: an update on the pharmacotherapy and management
Krisztina B. Gecse et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Impact of Race and Ethnicity in the Course and Outcome of Systemic Lupus Erythematosus
Luis Alonso Gonzalez et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2014)
Global prevalence of ankylosing spondylitis
Linda E. Dean et al.
RHEUMATOLOGY (2014)
Current issues in pediatric inflammatory bowel disease-associated arthropathies
Sabrina Cardile et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn's Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study
Chen-Wang Chang et al.
INTESTINAL RESEARCH (2014)
Epidemiology of Spondyloarthritis: A Review
Gunnstein Bakland et al.
CURRENT RHEUMATOLOGY REPORTS (2013)
IL-12 family cytokines: immunological playmakers
Dario A. A. Vignali et al.
NATURE IMMUNOLOGY (2012)
New advances in juvenile spondyloarthritis
Shirley M. L. Tse et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Methotrexate in peripheral spondyloarthritis including psoriatic arthritis: a need for further evaluation Is it time to change practice?
Maxime Dougados
RHEUMATOLOGY (2012)
Enthesitis in an Inception Cohort of Enthesitis-Related Arthritis
Pamela F. Weiss et al.
ARTHRITIS CARE & RESEARCH (2011)
Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?
Helenie Kefalakes et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Psoriasis associated with ulcerative colitis and Crohn's disease
A. D. Cohen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
MECHANISMS OF DISEASE Inflammatory Bowel Disease
Clara Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Reactive Arthritis: Clinical Aspects and Medical Management
John D. Carter et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2009)
Emergence of Crohn's Disease During Treatment with the Anti-Tumor Necrosis Factor Agent Etanercept for Ankylosing Spondylitis: Possible Mechanisms of Action
Boulos Haraoui et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Rheumatic manifestations of inflammatory bowel disease
Tatiana Sofia Rodriguez-Reyna et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
Robert D. Inman et al.
ARTHRITIS AND RHEUMATISM (2008)
Rheumatic diseases in China
Qing Yu Zeng et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort - Ethnicity as a risk factor
R. K. Saurenmann et al.
ARTHRITIS AND RHEUMATISM (2007)
Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis
D. van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2006)
Primary sclerosing cholangitis, inflammatory a bowel disease, and colon cancer
Ulrika Broome et al.
SEMINARS IN LIVER DISEASE (2006)
The gastrointestinal safety and effect on disease activity of etoricoxib, a selective Cox-2 inhibitor in inflammatory bowel diseases
Y El Miedany et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept:: Clinical and magnetic resonance imaging data
X Baraliakos et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks
JC Davis et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: An open-label trial
SD Flagg et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Classification of the spondyloarthropathies
PJ Healy et al.
CURRENT OPINION IN RHEUMATOLOGY (2005)
Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years
J Braun et al.
RHEUMATOLOGY (2005)
Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis
J Braun et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Efficacy and safety of infliximab in patients with ankylosing spondylitis - Results of a randomized, placebo-controlled trial (ASSERT)
D van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2005)
Results from an open-label extension study of etanercept in ankylosing spondylitis
J Davis et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study
TK Kvien et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis
A Calin et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Recombinant human tumor necrosis factor receptor, (etanercept) for treating ankylosing spondylitis - A randomized, controlled trial
JC Davis et al.
ARTHRITIS AND RHEUMATISM (2003)
Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis -: An open, observational, extension study of a three-month, randomized, placebo-controlled trial
J Braun et al.
ARTHRITIS AND RHEUMATISM (2003)
Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis
J Brandt et al.
ARTHRITIS AND RHEUMATISM (2003)
Uveitis and erythema nodosum in inflammatory bowel disease: Clinical features and the role of HLA genes
TR Orchard et al.
GASTROENTEROLOGY (2002)
Update on spondyloarthropathies
MA Khan
ANNALS OF INTERNAL MEDICINE (2002)
Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α
JD Gorman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
